Presentation is loading. Please wait.

Presentation is loading. Please wait.

Richard C. Dart, MD, PhD Executive Director, RADARS System

Similar presentations


Presentation on theme: "Richard C. Dart, MD, PhD Executive Director, RADARS System"— Presentation transcript:

1 Lisbon Addictions 2017 The Evolution of the Opioid Abuse Epidemic in North America October 24, 2017
Richard C. Dart, MD, PhD Executive Director, RADARS System Professor, University of Colorado School of Medicine

2 RADARS® System Conflict of Interest Statement
Most manufacturers of prescription opioids or stimulants subscribe to RADARS System. RADARS System is the property of Denver Health and Hospital Authority, a political subdivision of the State of Colorado. Subscribers receive information, but do not participate in development, data collection, or analysis of the data. They do not have access to the raw data. Employees are prohibited from personal financial relationships with any company. IN: EXPLAIN: OBS: OUT:

3 Supply of Legal Opioid Analgesics
The supply of legal highly addictive drug has increased in many countries. (I will go over details briefly) 2 minutes

4 What is the Problem We Need to Solve?
Filling the Balloon Chewed Crushed Intact Person in Pain Death Outcomes Addiction Overdose Susceptible Person Recreational Abuser Abuse of Other Drugs

5 Rudd et al. MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82.

6 Opioid Overdose Mortality in US is Primarily White, Non-Hispanic
> 80% White, Non-Hispanic Black, Non-Hispanic Hispanic CDC Wonder, analyzed by Kaiser Family Foundation:

7 Mosaic Surveillance of Prescription Drug Abuse
Acute Health Events Poison Center Program Non-Medical Use Survey of Non-Medical Use of Prescription Drugs (NMURx) Entering Treatment Survey of Key Informants’ Patients Drug Transactions Drug Diversion Program Entering Treatment Opioid Treatment Program StreetRx.com IN: EXPLAIN: OBS: OUT: Advanced Users/Targeted Investigations Researcher & Patients Interacting Directly (RAPID) Illicit Market Price StreetRx Program Internet Chatter Web Monitoring Program

8 Prescription Opioid Abuse is Declining in the US
Poison Centers Drug Diversion Substance Abuse Treatment Centers Dart RC, et al. Trends in Opioid Analgesic Abuse and Mortality in the United States. N Engl J Med 2015;372:241-8

9 Hydrocodone & Oxycodone Dominate Rx Opioid Abuse in US
RADARS Poison Center Program Intentional Abuse Exposures CDC Per 100,000 population

10 Evolution of Prescription Drug Abuse in US
WA Rx Guidelines Oxycodone ER Reformulation FL TIRF REMS ER/LA REMS HC-APAP Tramadol National Drug Take Back CDC Pain Guideline Oxycodone ER PDMP Other Opioids Other Opioids

11 Potential Effects of Interventions
Emptying the Balloon Chewed Crushed Intact Person in Pain ADF ADF Dth Outcomes OUD OD Guidelines PDMP Enforcement Susceptible Person Recreational Abuser Heroin Treat Abuse of Other Drugs

12 Percentage Drug Deaths Comparing 2010, 2014, 2015
Hedegaard H, et al. Drug overdose deaths in the United States, 1999–2015. NCHS data brief, 273. National Center for Health Statistics

13 Most Opioids Rudd et al. MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):

14 Divergence of Heroin and Rx Opioids - 2008
N Engl J Med 2015;372:241-8

15 Heroin and Other Drugs Push? Or Pull?
Alcohol Marijuana Opioid Abuser Availability Cost Setting Heroin Rx Opioid I honestly don’t think so. Here is my reasoning. The vast majority of peoply who end up using heroin have a long track record. They typically started with alcohol, then abused marijuana and, often, other drugs as well. At some point they are make a conscious decision on whether to try an opioid. They make this decision similar to consumers of other products – availability, cost and in the case of drug abuse – setting. Thus, the so-called push to heroin is actually a pull. Heroin is just the most available and cheapest form of opioid available today. Benzodiazepines Gabapentanoids Antipsychotics

16 Ever-Expanding List of Drugs of Abuse
Opioids (heroin, prescription analgesics, loperamide) Stimulants (methamphetamine, cocaine, Adderall, Concerta, synthetic cannabinoids) Cannabinoids (marijuana) Hallucinogens (LSD, peyote, ketamine) Antipsychotics (olanzapine) Novel psychoactive substances (NPS) “Designer Drugs” Any CNS active drug? Gabapentin, pregabalin Nicotine

17 Summary Prescription opioid abuse peaked and has subsequently decreased steadily Illicit opioid abuse transformed by new distribution methods and is increasing rapidly Deaths occur primarily due to fentanyl-laced heroin Substance abuse is complex Focusing on one or two agents may produce misleading


Download ppt "Richard C. Dart, MD, PhD Executive Director, RADARS System"

Similar presentations


Ads by Google